EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $158M
- YoY, 2025
- −2.6%
- 5-year CAGR
- +11.3%
- 10-year CAGR
- +12.2%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $158M | −2.6% |
| 2024 | $162M | +16.4% |
| 2023 | $139M | +9.9% |
| 2022 | $127M | +16.0% |
| 2021 | $109M | +18.0% |
| 2020 | $93M | +13.9% |
| 2019 | $81M | +14.5% |
| 2018 | $71M | +15.3% |
| 2017 | $62M | +8.3% |
| 2016 | $57M | +14.0% |
| 2015 | $50M | +3.3% |
| 2014 | $48M | +1.9% |
| 2013 | $47M | +12.6% |
| 2012 | $42M | +20.3% |
| 2011 | $35M | +19.5% |
| 2010 | $29M | +3.5% |
| 2009 | $28M | −1.4% |
| 2008 | $29M | — |